A. Bardet

Impact of COVID-19 on healthcare organisation and cancer outcomes

A. Bardet, Aldéric Fraslin, J. Marghadi et al. · European Journal of Cancer · 2021 · 183 citations · Full text

Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk

Barbara Pistilli, Angélo Paci, Arlindo R. Ferreira et al. · Journal of Clinical Oncology · 2020 · 134 citations · Full text

Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial

Patricia Pautier, Antoîne Italiano, Sophie Piperno‐Neumann et al. · The Lancet Oncology · 2022 · 110 citations

Unresectable Leiomyosarcoma, First-line Therapy, Surgical Oncology +7

LBA3_PR An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: Primary end-point analysis of LungART (IFCT-0503, UK NCRI, SAKK) NCT00410683

C. Le Péchoux, N. Pourel, Fabrice Barlési et al. · Annals of Oncology · 2020 · 93 citations · Full text

International Randomized Trial, Surgical Oncology, Radiation Medicine +11

Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study

Kausik K. Ray, Carlos Aguíar, Marcello Arca et al. · European Journal of Preventive Cardiology · 2024 · 54 citations · Full text